Could pharma’s legal attack on the IRA succeed in killing price negotiations?

Medicare’s newfound mandate to negotiate drug prices is well underway with the first wave of 10 drugs and their newly proposed prices bouncing between drugmakers and the government.

HHS sent out its proposed prices for the first 10 drugs on Feb. 1 and manufacturers responded this week with counter offers, President Joe Biden said on March 4.